Standard Lithium Ltd vs Health Care Select Sector SPDR Fund — how do they compare? Standard Lithium Ltd trades at $1.58 (market cap $398.07M), while Health Care Select Sector SPDR Fund trades at $170.81 (market cap $43.48B). The key difference: Health Care Select Sector SPDR Fund is far larger — about 109.2× Standard Lithium Ltd's market cap, and Health Care Select Sector SPDR Fund is trading nearer its 52-week high, Standard Lithium Ltd nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Standard Lithium Ltd for 23 Days and Health Care Select Sector SPDR Fund for 100 Days on average.
| SLI | XLV | |
|---|---|---|
Market Cap | $398.07M | $43.48B |
Volume | 1,564,155 | 11,121,431 |
Sector | Basic Materials | — |
52-Week High | $5.65 | $175.68 |
52-Week Low | $1.58 | $141.95 |
Typical Hold Time | 23 Days | 100 Days |
Enterprise Value | $260.98M | — |
Signals from Pluang's Aura AI — not financial advice
Standard Lithium (SLI) trades at $1.61, down 2.42% on the day, with mixed signals from technical indicators showing bearish moving averages but oversold RSI readings. The company remains pre-revenue with negative profitability metrics (ROE -15.55%, ROA -14.17%) but has shown improving quarterly EPS performance, beating expectations in recent quarters. Recent developments include progress toward a final investment decision for the South West Arkansas lithium project and new customer offtake agreements.
The investment case hinges on successful project execution, with analyst consensus strongly bullish (100% buy ratings) and a $3.83 price target representing 138% upside. Key risks include the pre-revenue status, negative cash flow from operations, and project timeline execution. The stock offers high-risk, high-reward exposure to lithium development with significant government and institutional support.
XLV trades at $168.16, down 0.39% on the day, with technical indicators showing a bearish bias as the ETF tests key support levels. The healthcare ETF maintains a competitive 0.08% expense ratio and offers diversified exposure to 60 S&P 500 healthcare stocks. Recent options activity shows increased put volume, suggesting some investor caution despite the sector's defensive characteristics.
The healthcare sector's defensive nature and potential Fed rate hike resilience provide stability, though technical weakness and political volatility around midterm elections present near-term risks. XLV's low-cost structure and broad diversification make it an efficient vehicle for healthcare exposure, but sector-specific headwinds like drug trial failures warrant monitoring.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Standard Lithium Ltd. is a company focused on the development of lithium projects in North America, with a primary focus on extracting lithium from brine resources. Their flagship projects aim to utilize proprietary, advanced direct lithium extraction (DLE) technologies to produce high-purity lithium compounds in an environmentally responsible manner. The company seeks to become a key domestic supplier to the growing electric vehicle and battery storage markets.
Read more on SLI →In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.
Read more on XLV →